Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs iShares Broad USD Investment Grade Corporate Bond (USIG) Price & Performance

Heron Therapeutics IncTrade
iShares Broad USD Investment Grade Corporate BondTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while iShares Broad USD Investment Grade Corporate Bond trades at $50.21. Which is the better fit depends on your goals.

HRTXUSIG
Market Cap
$61.47M
Sector
HealthFixed Income
52-Week High
$1.49$52.69
52-Week Low
$0.32$50.18
Enterprise Value
$168.21M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About iShares Broad USD Investment Grade Corporate Bond

USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.

Read more on USIG